Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). (Q52975817)

10 May 2018

title

Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). (English)

1 reference

10 May 2018

author name string

Bruhn C

1

1 reference

10 May 2018

Brockmöller J

2

1 reference

10 May 2018

Cascorbi I

3

1 reference

10 May 2018

Roots I

4

1 reference

10 May 2018

Borchert HH

5

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 December 1999

1 reference

10 May 2018

published in

Biochemical Pharmacology

1 reference

10 May 2018

volume

58

1 reference

10 May 2018

issue

11

1 reference

10 May 2018

page(s)

1759-1764

1 reference

10 May 2018

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Human acetyltransferase polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Diverse point mutations in the human gene for polymorphic N-acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Arylamine N-acetyltransferase in human red blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Nomenclature for N-acetyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

Reversed-phase high-performance liquid chromatographic assay for the determination of the in vitro acetylation of p-aminobenzoic acid by human whole blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900269-5

10.1016/S0006-2952(99)00269-5

7 January 2021

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018